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The biosynthesis of Peps, a lanthionine-containing antimicrobial peptide, is directed by the 20-kbp 
plasmid pED503. We identified a 7.9-kbp DNA-fragment within this plasmid which covers the informa- 
tion for Peps synthesis in the homologous host Staphylococcus epidermidis S which has been cured of 
pED503. This fragment contained, in addition to the previously described structural gene pepA and the 
immunity gene pep1 [Reis, M., Eschbach-Bludau, M., Iglesias-Wind, M. I., Kupke, T. & Sahl, H . 4 .  
(1994) Appl. Env. Microbiol. 60, 2876-28831, a genepepTcoding for a translocator of the ABC transpor- 
ter family, a gene pepP coding for a serine protease and two genes pepB and pepC coding for putative 
modification enzymes ; the gene arrangement is pepTIAPBC. We analyzed the biosynthetic genes with 
respect to their function in Peps biosynthesis. Deletion of PepT reduced Pep5 production to about lo%, 
indicating that it can be partially replaced by other host-encoded translocators. Inactivation of PepP by 
site-directed mutagenesis of the active-site His residue resulted in production of incorrectly pi-ocessed 
Peps fragments with strongly reduced antimicrobial activity. Deletion of pepB and pepC leads to accumu- 
lation of Pep5 prepeptide in the cells without excretion of processed peptide. A pepC-deletion clone did 
not excrete correctly matured Peps but it did produce fragments from which serine and threonine were 
absent. Only one of these fragments contained a single lanthionine residue out of three expected while 
the remaining, unmodified cysteine residues could be detected by reaction with Ellman's reagent. These 
results demonstrate that PepC is a thioether-forming protein and strongly suggest that PepB is responsible 
for dehydration of serine and threonine. 
Keywords: lantibiotics ; Peps biosynthetic gene cluster; PepC, thioether-forming enzyme; PepP, serine 
protease. 
Peps is a tricyclic peptide produced by Staphylococcus epi- 
dermidis S (Sahl and Brandis, 1981) which belongs to the family 
of lantibiotics, a designation introduced to characterize lanthio- 
nine containing peptides with antimicrobial activity (Schnell et 
al., 1988). In contrast to conventional peptide antibiotics, which 
are synthesized by multienzyme complexes, lantibiotics derive 
from gene-encoded precursor peptides. These precursors consist 
of a leader sequence and a propeptide part which is posttransla- 
tionally modified to give the mature lantibiotic. It was proposed 
that in a first modification step the serine and threonine residues 
of the propeptide part are dehydrated to didehydroalanine (Dha) 
and didehydrobutyrine (Dhb) (Schnell et al., 1988). Such dehy- 
drated prepeptides have been isolated from S. epidermidis 5 
(Weil et al., 1990). In a second step thiol groups of cysteine 
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ADbreviutions. Lan, lanthionine; MeLan, 3-methyllanthionine; Dha, 
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Note. The novel nucleotide sequence data published here have been 
deposited with the EMBL sequence data bank and are available under 
accession number 249865. The novel amino acid sequence data have 
also been deposited with the EMBL sequence data bank. 
residues react with the double bonds of some of the Dha and 
Dhb residues to form lanthionine or methyllanthionine, respec- 
tively. Some lantibiotics contain further modified residues such 
as D-Ala (Skaugen et al., 1994) or the C-terminal S-aminovinyl- 
cysteine (Kupke et al., 1994). For nisin it has been demonstrated 
that, after modification of the propeptide part, the prelantibiotic 
is exported from the cell, followed by removal of the leader 
sequence (Van der Meer et al., 1993). 
Obviously, such a maturation pathway requires a dedicated 
biosynthetic machinery composed of several proteins. The genes 
for these proteins have been found to be arranged in gene clus- 
ters as described for nisin (Engelke et a]., 1992, 1994; Kuipers 
et al., 1993; Van der Meer et al., 1993), subtilin (Klein et al., 
1992, 1993; Klein and Entian, 1994; Chung et al., 1992; Chung 
and Hansen, 1992) and epidermin (Schnell et al., 1992). Typi- 
cally, these clusters include genes for specialized peptidases be- 
longing to the subtilisin family of serine proteases for proteolytic 
processing, an export protein of the ABC transporter family, pro- 
teins involved in immunity, and two component regulatory pro- 
teins. In addition, in all of these clusters two genes designated 
lanB and lanC were found, the corresponding proteins of which 
do not have any similarity to known sequences. As dehydration 
of peptide hydroxyamino acids and thioether formation are hit- 
herto undescribed reactions, novel catalysts were expected to be 
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found, thus making these LanB and LanC proteins likely candi- 
dates. However, no experimental evidence concerning the role 
of these two proteins has been reported so far. 
Lantibiotic gene clusters may be located on the chromosome 
as in the case of subtilin (Banerjee and Hansen, 1988), on plas- 
mids as in the case of epidermin (Schnell et al., 1988), or on a 
transposon as shown for nisin (Dodd et al., 1990). The structural 
gene for Pep5 biosynthesis, pepA, is located on the 20-kbp plas- 
mid pED503 in the producer strain S. epidermidis 5 (Kaletta et 
al., 1989). Upstream ofpepA, the immunity gene pepl was found 
which confers protection against Pep5 to the producer strain, 
while downstream an open reading frame starts which codes for 
the N-terminal fragment of a putative protease (Reis et al., 
1994). A 6.8-kbp fragment of pED503 that comprises pepl, pepA 
and a further 5.3-kbp of downstream sequence is sufficient for 
Pep5 biosynthesis in a variant of S. epidermidis 5 that has been 
cured of pED503, although the production rate of this clone is 
lower than that of the wild-type strain (Bierbaum et al., 1994). 
Here we report the nucleotide sequence of the 6.8-kbp fragment 
and of an additional 1.072-kbp upstream of pepl. We identified 
and functionally analyzed the processing protease PepP and the 
transporter PepT. In addition, we found the genes for the puta- 
tive modification enzymes PepB and PepC and present, for the 
first time, experimental evidence for their role in lanthionine 
biosynthesi s. 
MATERIALS AND METHODS 
Bacterial strains and plasmids. The bacterial strains listed 
in Table 1 were kept as glycerol stock cultures at -70°C or 
subcultured weekly on blood agar. Both Escherichia coli strains 
were used as hosts for recombinant DNA, E. coli BMH 71-18 
mut S and the vector PALTER were used for site-directed muta- 
genesis. The plasmids pBR322, pEMBLl8+/pEMBL19+ and 
pUC19 were used for transformation of E. coli; pCUl is an E. 
colilStaphylococcus shuttle vector, which was kindly provided 
by R. Rosenstein and F. Gotz (Tubingen; Augustin et al., 1992). 
DNA cloning, sequencing and amplification by the poly- 
merase chain reaction (PCR). Plasmid DNA of S. epidermidis 
5 was purified as described previously (Reis et al., 1994). Plas- 
mid DNA of E. coli strains was isolated by the methods of 
Holmes and Quigley (1981) or Birnboim and Doly (2979); DNA 
for sequencing was purified on Qiagen 20 columns (Diagen, Hil- 
den, FRG). Restriction enzymes and T4 DNA ligase were sup- 
plied by Boehringer (Mannheim). E. coli strains and S. epider- 
midis 5 Peps- were transformed by electroporation (Augustin 
and Gotz, 1990). 
For determination of the sequence downstream of pepP, the 
6.8-kbp insert of pGB7 was digested with the restriction en- 
zymes Hind11 and EcoRI. The fragments obtained were cloned 
in pUC19 or pEMBL19’ and designated pCM4/1-4/5 (Table 
I). In order to sequence the DNA upstream of pepl, deletion 
clones of pCMl (designated pJS9 to pJS12, Table 1) were con- 
structed using the double-stranded nested deletion kit from Phar- 
macia. The instructions of the manufacturer were modified as 
follows : the restriction enzymes EcoRI and A d 1  were used to 
linearize the plasmid; deletion reactions were performed without 
NaCl at 30°C; samples were taken at 1-min intervals; after the 
S1 nuclease digest, Klenow polymerase was used to obtain a 
sufficient number of blunt ends; ligation was performed in the 
presence of 0.25% Nonidet P40. The clones were hybridized 
with a PCR fragment covering pepA which was labelled with 
[’2P]dATP using the random primed DNA labelling kit from 
Boehringer (Mannheim). Southern hybridization was performed 
according to established protocols (Sambrook et al., 1989). 
Clones lacking progressively about 300 bp were selected. 
Double-stranded plasmid DNA was sequenced by using the 
dideoxynucleotide chain-termination method (Sanger et al., 
1977), the T7 sequencing kit (Pharmacia) and [”SjdATP[aS] 
(Amersham). Oligonucleotides used for sequencing and amplifi- 
cation were synthesized with a 391 PCR Mate (Applied Biosys- 
tems). Sequence data were analyzed with ClustalW (kindly pro- 
vided by D. Higgins; Higgins et al., 1992; Thompson et al., 
1994), readseq (kindly donated by D. Gilbert), the GENIUS HU- 
SAR program suite at the DKFZ (Heidelberg) and the Genetic 
Data Environment program suite (kindly provided by S. Smith). 
RNA isolation and Northern hybridization. RNA was pre- 
pared by the minilysate method of Holmes and Quigley (2981) 
as modified by Oskouian and Stewart (1990) for isolation of 
RNA from staphylococci. S. epidermidis 5 cells were grown in 
tryptic soya broth medium (Oxoid, Basingstoke, England: 17 g/1 
Bacto tryptone, 3 g/l Bacto soytone, 2.5 g/l Bacto dextrose, 5 g/l 
NaCI, 2.5 g/l Na,HPO,) containing 0.7% (mass/vol.) glycine to 
an absorbance of 1.0 at 578 nm, pelleted, suspended in 50% 
sucrose, 20% Triton, 0.5 M EDTA, 1 M Tris, pH 6.8 and incu- 
bated with lysostaphin (0.71 mg/ml) for 40 s at 100°C. After 
addition of 20 U RNasin (Promega Corporation, Heidelberg), the 
cold sample was centrifuged and the RNA was precipitated from 
the supernatant with ethanol/3 M sodium acetate pH 4.8. After 
digestion with DNase I (Boehringer, Mannheim) according to 
Ambulos et al. (1987) and denaturation with glyoxal/dimethyl- 
sulfoxide (McMaster and Carmichael, 1977), total RNA was 
separated on a 1.75 % agarose gel (Seaplaque, FMC Corporation, 
Rockland, USA) using 10 mM sodium phosphate, pH 7. Vacuum 
blotting was performed with a Vacu Gene XL (Pharmacia) 
within 90 min and a suction of 50 cm H,O. Complete RNA 
transfer was controlled by staining with ethidium bromide. After 
a short incubation in 1 mM EDTA, 10 mM Tris pH 8 at 96°C. 
the filter was dried for 2 h at 80°C. 
As hybridization probes [”PIdATP randomly primed PCR 
fragments ofpepl and pepA were used. These were synthesized 
according to Saiki et al. (1988) using pMR4 as a template; the 
primers were : pepI-5’ [5’(ATGAACATATACTTAAAAG- 
TAAT)3’], pepI-3’ [5’(TAAAGTTTATCTTTTTTGTTGC)3’] ; 
pepA-5’ [5’(TATTTATAGAGGAGGTGGTTA)3’], pepA-3’ 
[5’(GAGTGGTTTCCCATACTATT)3’]. Hybridization was per- 
formed using the formamide protocol and Zeta-probe mem- 
branes (BioRad). 
For transcription start site analysis, primer extension studies 
were performed using the following oligonucleotides : pepA-5‘ 
with the sequence 5‘-GGTTCAAGTTCATCAGTG-3’ and pepl- 
5‘ with the sequence 5’-CCATTGCTTAGTCGTTA-3’; both 
were labelled with the 5’-labelling kit from Boehringer (Mann- 
heim; Maxam and Gilbert, 1980). The primer extension was per- 
formed with reverse transcriptase (Boehringer, Mannheim) as 
described by Pooiman et al. (1990). The half-life of the pepl 
and pepA mRNA was measured by the rifampicin (0.1 mg/ml) 
procedure of Ambulos et al. (1987). 
Site-directed mutagenesis. Site-directed mutagenesis of 
PepP was performed with a commercial phagemid system as 
previously described for Pep5 mutant peptides (Bierbaum et al., 
1994). The following mutagenic oligonucleotide was used to ex- 
change the active-site His for Pro (the mismatch is underlined): 
5’( GATTACACTGGGCCTGGAACTCAAATAATA)3’. 
Purification of Pep5 peptides and Western blot analysis 
of pre-Pep5. For purification of Pep5 peptides 2 1 tryptic soya 
broth was directly inoculated with the respective S. epidermidis 
clone and incubated to an absorbance of 3-4 at 600 nm. Cells 
were removed by centrifugation and the supernatant directly 
used for purification which included adsorption chromatography 
on XAD2 adsorbent (Serva), cation-exchange chromatography 
and HPLC reverse-phase chromatography as described pre- 
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Table 1. Bacterial strains and plasmids used in this study. 
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Bacterial strains and plasmids Characteristics References 
S.  epidermidis 5 
S. epidermidis 5 Pep5- 
S. carnosus TM300 
S. simuluns 22 
Micrococcus luteus ATCC 4698 
E. coli 71-18 
E. coli BMH 71-18 mut S 
E. coli JM 83 
E. coli JM 109 
pBR322 
pEMBL18+/19+ 
pUC19 
pCU1 
PALTER 
pMR4 
pMR7 
pGB7 
pGB9 
pGBl0R 
pGRO 1 
pCMl 
pCM4/1 
pCM4/2 
pCM4/3 
pCM4/4 
pCM4/5 
pCM7 
pSZl 
pJS9 -pJS12 
wild-type strain; contains five plasmids ipED503-505) ; pED503 
(20 kbp) confers Pep'lmm' phenotype 
cured variant of S. epidermidis 5,  lacking pED.503; Pep-lmm phenotype 
cloning host and indicator strain 
indicator strain 
indicator strain 
F-lacLq(lacZ) MI5 proAB(1ac-proAB) thi supE 
variant strain of E. coli 71-18, defective in DNA mismatch repair 
thi ara (lac-proAB) strA (IacZ) MIS 
supE' (lac-proAB) hsdR17 dam[F'traD36 pro AB' lacIqI(lacZ) MIS] 
AmpR TetR 4.36-kbp low-copy vector 
AmpKlacZ, 3.96-kbp vector 
AmpRlacZ, 2.68-kbp high-copy vector 
AmpKCm", 4.95-kbp shuttle vector 
AmpRTetR, 5.68-kbp phagemid 
2.0-kbp BglII fragment of pED503 cloned into pCUl 
540-bp PCR fragment cloned into pCUl 
8.3-kbp BamHI fragment of pED503 cloned into pEMBL18+ 
6.8-kbp SphI-BamHI fragment of pSZl in pCUl 
4.8-kbp KpnI-BumHI fragment of pSZI subcloned into pCUl 
6.2-kbp KpnI-BamHI fragment of pED503 in pCUl 
pCB10R with the mutation H53P in PepP 
5.0-kbp HindIII fragment of pED503 in pBR322 
2.0-kbp HindIII fragment of pGB7 subcloned into pUCl9 
2.2-kbp EcoRI fragment of pGB7 subcloned into pUC19 
2.0-kbp HindIII fragment of pCB9 subcloned into pUC19 
1.6-kbp EcoRI fragment of pGB7 subcloned into pUC19 
0.9-kbp HindIII fragments of pCB7 subcloned into pEMBLl 9+ 
deletion clones of pCMl 
3.8-kbp kpnI-SpeI fragment derived from pGB9 and 1.39-kbp 
Bg[II-KpnI fragment derived from pMR4 subcloned into pCU? 
Sahl and Brandis, 1981 
Ersfeld-DreRen et al., 1984 
Schleifer and Fischer, 1982 
Sahl and Brandis, 1981 
Sahl and Brandis, 1981 
Sambrook et al., 1Y89 
Zell and Fritz, 1987 
Vieira and Messing, 1982 
Ymisch-Perron et al., 1985 
Bolivar et al., 1977 
Dente et al., 1983 
Vieira and Messing, 1982 
Augustin et al., 1992 
Dotto et al., 1981 
this study 
Reis and Sahl, 1991 
Bierbaum et al., 1994 
Bierbaum et a]., 1994 
Bierbaum et al., 1994 
Bierbaum et al., 1994 
this study 
this study 
this study 
this study 
this study 
this study 
this study 
this study 
this study 
viously (Sahl and Brandis, 1981; Sahl et al., 1985). Amino acids 
of peptide hydrolysates were analyzed after derivatization with 
o-phthaidialdehyde (Sahl et al., 1985). 
The purified peptides were characterized by electro-spray 
mass spectrometry and by Edman degradation as previously de- 
scribed (Weil et al., 1990). For determination of free thiol 
groups, peptides were treated with Ellman's reagent, 5,5'-dithio- 
bis-(2-nitrobenzoic acid). The reagent was dissolved in ethanol 
( 1  mglrnl) and mixed with an equal volume of buffer (0.4 M 
ammonium acetate pH 8.0) shortly before use. Aqueous solu- 
tions of the peptides were supplemented with an equal volume 
of the reagent mixture and incubated for 30 min at room temper- 
ature before mass determination. For reduction of disulfide 
bonds prior to Ellman derivatization, peptides were treated with 
2 mM dithioerythritol fos 30 rnin followed by addition of a 
threefold excess of Ellman's reagent. Reduction of disulfide 
bonds before HPLC was achieved by treating the peptides with 
0.2 mM dithioerythritol in 0.2 M ethylmorpholine pH 8. 
For semiquantitative comparison of Pep5 production by dif- 
ferent clones a rapid one-step procedure for Pep5 enrichment 
and subsequent SDSPAGE has been described (Bierbaum et al., 
1994) ; Western blots of prepeptides were performed according 
to Reis e t  al. (1994). 
Nucleotide sequence accession number. The nucleotide se- 
quences presented here have been deposited at the EMBL data 
bank under accession number 249865. 
RESULTS 
The Pep5 biosynthetic gene cluster. Previous work has shown 
that Pep5 production in S. epidermidis 5 depends on the pres- 
ence of plasmid pED503 (Ersfeld-DreBen et al., 1984) and that, 
in a pED503-cured variant, production can be restored with a 
6.8-kbp fragment of this plasmid (Bierbaum et al., 1994). We 
further subcloned this fragment using the restriction sites indi- 
cated (Fig. 1) and obtained its entire sequence (Fig. 2). Down- 
stream of the immunity gene pepl  and the Pep5 structural gene 
pepA (Reis et al., 1994) we identified three further open reading 
frames which, on the basis of sequence similarity to proteins in 
other lantibiotic gene clusters, were designated pepP, pepB and 
pepC. Moreover, we detected the start of a fourth open reading 
frame on the opposite strand upstream of pepI, of which the full 
sequence could not be determined due to the length of the frag- 
ment. This gene was completed by sequencing deletion clones 
pJS9 to pJS12 derived from pCMl (Fig. l), and the correspond- 
ing protein was found to have sequence similarity to lantibiotic 
translocators of the ABC transporter family. Thus, the Pep5 bio- 
synthetic gene cluster covers approximately 7.9 kbp and com- 
prises pepTZAPBC (Fig. 1, 2). 
Transcriptional aspects. Closer inspection of the DNA se- 
quence suggested the presence of two inverted repeats with fea- 
tures of rho-independent transcriptional terminators. The first 
Meyer et al. ( E m  J .  Bioclzem. 232) 48 1 
&/I1 Kpnl E o R I  Hind111 Spel 
Sphl HzndlIl B$II Hind111 EcoRI 
A 
L I I 1  I I 1  I I I I  I 1  I I  I I 1  I I 
+-ic 
Pep1 -1 
II$ 
PCPC 
+ H-l pepB 
P ~ P T  P ~ P A  Pepp 
C pMR4 
pGB7 
pGBlOR 
pGROl 
7H53P 
4 pCMl 
pCM4I1 
pCM412 
pCM41.1 
pCM414 
- pCM415 
Fig. 1. Organization of the Pep5 biosynthetic gene cluster. (A) Re- 
striction map of the 7.9-kbp segment of the plasmid pED503 covering 
the DNA sequence information for Pep5 production. (B) Organization 
of the Pep5 biosynthetic genes. (C) Subcloned fragments of the gene 
cluster; dotted lines indicate the restriction sites used for cloning. 
putative terminator with a calculated free energy of -56.9 kJ/ 
mol is located in the short non-coding segment between pepA 
and pepP and may allow partial readthrough (Reis et al., 1994), 
while the second inverted repeat follows 110 bp downstream of 
pepC and is probably strong enough (-78.7 kJ/mol) for tran- 
scription termination (Fig. 2). Potential promoters with reason- 
able similarity to published consensus sequences were only de- 
tected in front of pep1 and pepA. Northern blot analysis with 
probes for both genes did not detect any transcripts longer than 
expected for monocistronic mRNA (Fig. 3). The pep1 transcript 
was approximately 300 bases long, had a half-life of 1.5 min 
(Fig. 3) and started 42 bases in front of the respective ATG co- 
don (Fig. 2). The pepA mRNA was of similar size (Fig. 3), but 
more stable (half-life of 7-10 min) and started 52 bases in front 
of the pepA start codon. On the basis of these start sites, pro- 
moter sequences are proposed as indicated (Fig. 2). The -35 
region of the potential pep l  promoter (TTGACA) is identical to 
the E. coli consensus sequence and the - 10 region for the pepA 
promoter (TATAAA) has reasonable similarity to lactococcal 
-10 sequences (e.g. Chassy and Murphy, 1993). 
The protease PepP is necessary for correct processing of 
Pep5 Adjacent to pepA, separated by 61 base pairs, follows 
pepP coding for a 285-amino-acid gene product with a calcu- 
lated mass of 32.4 kDa (Fig. 2). PepP shows sequence simi- 
larities to subtilisin-like serine proteases, especially the con- 
served regions containing the amino acids of the active-site 
Asp20, His53, Ser228 and Asn145 of the oxyanion hole (Fig. 4). 
PepP is an overall hydrophilic protein without any clusters of 
hydrophobic amino acids. A prepro-sequence which is common 
with most other serine proteases (Siezen et al., 1991) is also 
missing, suggesting that it is not exported but localized in the 
cytoplasm. 
In order to determine whether PepP is active and necessary 
for Pep5 biosynthesis, the protease was inactivated by site-di- 
rected mutagenesis exchanging the active-site His53 for Pro. 
The resulting clone S. epidermidis 5 Pep5- pCRO1 accumulated 
unprocessed prepeptide inside the cells but did not excrete any 
prepeptide into the culture medium (Fig. 5B, lanes 4, 5, 6 ;  com- 
pared to the wild-type strain, lane 2). Also, Pep5 could not be 
found in the supernatant (Fig. 5 A, lane 5) ,  yet some antibacterial 
activity was detectable after partial enrichment. Using the Pep5 
purification protocol (Sahl et al., 1985), a number of peaks were 
found to elute from the HPLC C18 column at a lower concentra- 
tion of acetonitrile as compared to Pep5. These peaks contained 
mixtures of peptides with molecular masses lower than 3488 Da 
which were identified as fragments of Pep5 by N-terminal se- 
quencing and mass spectroscopy. The major components were 
Pep5 17-34 (with a mass of 1899.24 Da and a N-terminal se- 
quence of Leu-Lys-Ala), Pep5 6-34 (3106.15 Da, Ile-Arg-Ah) 
and Pep5 15 - 34 (21 10.5 Da, Lys-block). Moreover, S. epider- 
midis 5 PepY pGBlOR @epIAPBCj produces, in addition to 
correctly dehydrated Pep5, significant amounts of a Pep5 pep- 
tide with a surplus water molecule that corresponds to the pres- 
ence of a ser residue in amino acid hydrolysates (Bierbaum et 
al., 1994) ; corresponding peptide fragments with an additional 
mass of 18 Da were also detected (Pep5 17-34, 1917.5 Da; 
Pep5 6-34, 3124.5 Da; Pep5 15-34, 2128.5 Da). Thus, in the 
absence of functional PepP, the Pep5 prepeptide is processed at 
different sites by other host proteases present, indicating that 
PepP is essential for correct processing of Pep5. Additionally, 
only in the PepP-deficient clone can a peptide be detected by 
immunoblotting with anti-leader peptide antiserum which has 
approximately half the mass of the prepeptide (Fig. 5 ,  lane 4). 
Apparently, this peptide represents the incorrectly processed 
leader peptide which is not subjected to rapid degradation when 
additional amino acids are attached to its C-terminus due to pro- 
cessing at an incorrect site in the propeptide part of pre-Pep5. 
Activity determinations of the Pep5 fragments against Sfuphylo- 
coccus simuluns 22 gave minimal inhibitory concentrations of 
0.5-3.0 mg peptide/ml as compared to 1.2 ng/ml for native 
Pep5, i.e. native Pep5 is six orders of magnitude more active 
than the fragments; this corresponds to the almost complete loss 
of production of antibacterial activity by the PepP-deficient 
clone as compared to the wild-type strain. 
The modification enzymes PepB and PepC. Downstream of 
pepP, with an overlap of 14 bp and shifted by +1 base pair, a 
large open reading frame starts which codes for a protein of 
967 amino acids and of a calculated molecular mass of 11 6 kDa 
(Fig. 2). This putative protein PepB has sequence similarity to 
NisB (Engelke et al., 1992), EpiB (Schnell et al., 1991) and 
SpaB (Gutowski-Eckel et al., 1994). Although the overall 
amount of identical amino acids between these LanB proteins is 
only in the range of 20%, several segments are highly conserved 
(Fig. 6). Such segments are between residues 80 and 110 (RS/ 
TTPFNGXXS) and the C-terminal YXXEXXRYCG motif 
around position 850 with two further conserved Glu residues in 
its close vicinity; however, any predictions as to the functional 
importance of these segments seem premature. Hydrophobicity 
plots indicate that PepB in accordance with other LanB proteins 
is rather hydrophilic and that it has only one major hydrophobic 
stretch in the C-terminal part. 
Downstream of pepB and with a -1 base pair shift follows 
pepC coding for a putative protein of 398 amino acids with a 
calculated molecular mass of 42.2 kDa (Fig. 2). PepC has signif- 
icant sequence similarity to the other LanC proteins described 
so far with identity values slightly higher than calculated for 
PepB. Amino acid sequence alignments reveal several segments 
with significant similarity. Most of these segments contain 
amino acids with inert side chains and a number of regularly 
positioned Gly residues which could be of structural importance. 
However, towards the C-terminus some conserved sequence 
clusters contain residues which may be functionally relevant 
such as the NXGXAHGXXG around position 230, the 
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P e p T T K K N I P V A F S V N E L V N K S D Y S F Y V S N F I L E K N Q P I N E L N V  
P e p T K N E E V P E N L I G Y I R K S A G K S S K Y E T I L T S I E S I P S S L Q I V  
P e p T Y F I M S V L T G S T I A G V A I R Y G G Y S L I I G I M V L L L I S T F P Q L  
P e p T I A I I K A H K I W L K Y I S S L K E K T N N L E F E E N T S I K V L R I A S I  
P e p T V R G I T G T F D A V K Q Q T K F S L K E I I N G L P I I V M L F I P I I I F T  
P e p T L L T M K W D M I F L M T I S G I L T I F S P I I A P L K Q S I F N N I L S T D  
P e p T D T I R S I L Q G S E N K D F F S T N L F L I H K U L I S R I S Y I I K E G V K  
P e p T I L L F L G L G S F I A D L L F H L I L F V I F K L E L T Q K V L L D I L N G T  
P e p T L L P V I I E T I S G I S S I I I A I I F L S K P W K I K S F L F F L P N E K K  
TATAAACAATACTAAAAATTAATTTATTACTACTCAAGGATATGGGCATTAAAAGGGTAATAGATTTTTATATTAAACTAGACGCCAAGAATTATCAGCTATTCGCTACGGTTAATATTA 
GCATCAGGATAAAACTTTATTCAATAATTCACGTAACTAAAAAAAAAGTGAAAGTGATAGATTTGATCGGCAACGAAGTAGGTTGTTATTCTATAGTCCTAAAAATTAATTTAAAGA 
ACGTTATAATTAGGAGACAAAAACAG~GGT~~CAAAATACGGCGAAAGAGGTTAAACTCTCAGCATAACTACTCCATTTAATGATTATTTTAGTACTCTTAAACGGTTTTATCTTAT 
CATAAGATTAAGTAGTAGTCTATATAATAAT~ATGAGGTATG~TTACAATAGAGATTAA~GGGCAAGTAGTAATATAATAAAACGTAATGCATAGGGTTAAATTATGCGGTAAAAAA 
ATTTAGATATAGTATTTATCTTACAGGGGGTATTATTTAGGGAGGTGATAGTCGAAATATGTCAGATGATTAATTTAAATTCTATCAT~GAAAGGACTAGGACTTCCTGGTTGTTATCG 
ACAAAAAAATAAATATCCTTGTCGCTTTCTTTGTAAAAGGTCATGTAAAAATCTTAGTATTCTTTTTATATGA~TAATTTTTACTCAAGAAATAAAACCCCATATAAAAGATTTAAGTG 
GAATAAAAGAACATGCCCCAGTAAATTTTAAGGTATTTAAGCAAATGACCGAGGGAATCTTGAAAATATGAGCCAATAATTACAACTTTAAAGACT~AACCACTTGACTCAA~TATTG 
TATTTTATAGTATCTTTGATTTCATGGT~TCATTACCGCGGATGACGTTAAGATATAGGGGGTATACTATCATAATATGGTTAGTAATGATTATCCTCTTACGATCATTTTCCAACATT 
ATAACGATAATAGAATCGTACGAATTACAAATCAAATATTTATGACCTATCAAAAAGAAAACACAATAAATTGAGTTTGAGAAGTAATCATCTTTAAAATTGATTT~TTATCGACTATA 
ATGTGCAGGATATCACGGACATTTTAGTCGTTGAAAAACAACTCAAAATTTTCTATCAAAGAGATAATATAATGGATTACCATATTATTGGTAATCTTTATATCCTTAATATTATTTTCA 
ATTATTTCAGTAAAAGGTTAGGTAATATTTTTCGTATCATTATCTTGGATATTCACAATATTTTCTTCCATATTAACGTCCATTAAAAACTCTTTATTTTAACAAATAATTCCTTCATAG 
TAGTCAATAAGACGACTAATTAACAGGTCTAAGTAAAAATAGTTTTTTTGATCACAAATTTTTTTCCTATACAAAGGTATTATAACTAGACTAACTTATATATTAAAAAAGCGGTTGAAA 
CTAATTAT~TTATTCGGATTAGGTGATTTTTATCGTAGATCATTTTTGTAATCTTAATTTTTATGATACTTAAAATTAAGATTACAAACAAATTGATCATCTAGATAATTCAATGGGCA 
ATCTTCTCCCTGATACTAAAGTCACTATGACGGCTACCTTCTTTATTAATAACGTTATTATTTATT~TGAATCCGGTAAATTAAAAACTCTTATTTTTTTTATCACCCAAAAGAAAAAA 
5'-AATAAAACCTTTCATAACTAATATTTATTTTCTATCAGGTATTAAAAAAATTTTACAAAAACAGAGAAAATATTATACGATGCTAATAAAAGTATAACATGGTAAATAATATCATAA 
GTATTATTTTkATTGATTATAAATAAAAGATAGT-5 '  
RBS 
PepT M 
120 
571 
240 
561 
360 
521 
480 
481 
600 
441 
720 
401 
840 
36 1 
960 
321 
1080 
281 
1200 
241 
1320 
201 
1440 
161 
1560 
121 
1680 
81 
1800 
41 
1320 
1 
p-35 p-10 1 transcription start RBS 
CTTOTTTATGTCTACTTTGAATATACTTTTTTG~CACATATACT 2040 
PepI M N I Y  4 
TAAAAGTAATTTTAACTTCTTTATTTTTTGCTTTAATAATTTTTATTGT~ACTTATATAACGACTAAGCAATGGGGAACATCGTTAGGTTTTTCATCTTTATCATTTATCGGTAACTTTA 2160 
P e p I L K V I L T S L F F A L I I F I V T Y I T T K Q W G T S L G F S S L S F I G N F  44 
p-35 p-10 1 transcription start 
TTTACGATTATTCAACGAAATTAAGTGATAAAAAATATGAAAAAAGAATAAATAGCAACAAAAAAGATAAACTTTA-AAATAATTAAT~~AATGTA~GTTTTTTTCT 2280 
P e p I I Y D Y S T K L S D K K Y E K R I N S N K K D K L r  
RBS 
ATATTGTGATAACATTATATTTATAG~GGTTATATATGAAAAATAACAAAAATTTATTTGATTTAGAAATTAAAAAAGAAACAAGTCAAAACACTGATGAACTTGAACCTCAAA 
PepA M K N N K N L F D L E I K K E T S q N T D E L E P Q  
P e p A T A G P A I R A S V K Q C Q K T L K A T R L F T V S C K G K N G C K r  
CTGCTGGACCAGCGATTACAGCTTCTGTGAAACAATGTCAGAAAACTTTGAAAGCTACGCGTTTATTTACAGTGTCTTGCAAAGGAAAAAACGGATGTAAATAGTATGGG~ 
RBS _ _  
TAATTAAATAATAATGAGAGTGGTTTTTTGTAT~AAAATGAACAGTAATCATACATATATAAAACAAACAATTACGGATAGTATATTATTTATTGATAGTGCATGTGATTTT 
PeDP M K S N H T Y I K Q T I T D S I L F I D S G C D F  
AAACATCCGGAATTACAACATAATATTATTTTAAAGCAGAGCAAAAGTTTTGTGGACGATAATATCAGTGATTACACTGGGCATGGAACTCAAATAATAAGCGTACTGACAGGAAAGCAT 
TATATATCAGGATTCCTTCCTAATATTAATATTGTATTATATAAAGTTACAAATTTTTATGGAAAAAGTAAAGCAA~GATATATATAAAGCTTTAAAAATTGGGATTAAAAATAATTTT 
AAAGTTATAAATATAAGTTTCTCAGGTGAAATATACGATAAAAAATTAATGAAAAAATTTCAAAGTATTATATATGAAGCTTATAAAAAAAATATAGTAATTTGCTGGAGTTCAATGAAT 
AATCTACAAAAATCTGCTAATCATGGAAATAAAAACATGGTACCTAATCAATTAGAAAAAGTTTTCAAAATCGGCGATTTAAACTATTATAATTCGGTTGATTTTGTT~TCCAGGTGGA 
P e p P K H P E L Q D N I I L K Q S K S F Y D D N I S D Y T G H G T Q I I S V L T G K H  
P e p P Y I S G F L P N I N I V L Y K V T N F Y G K S K A I D I Y K A L K I G I K N N F  
P e p P K V I N I S F S G E I Y D K K L H K K F Q S I  I Y E A Y K K N I V I C W S S M N  
P e p P N L Q K S A N H G N K N N V P N Q L E K V F K I G D L N Y Y N S V D F V A P G G  
GGTAATAGTATAGCTACCTCCTATGCTTCAGGATGCTTTATGTTAATAATTAGTACTTTTAAAAATAAAAACAAACGGTATCCGAGTATAAATGAAATAATATCGTTAATATCGAAGTAT 
P e p P G N S I A T S Y A S G C F H L I I S T F K N K N K R Y P S I N E I I S L I S K Y  
RBS 
CACGATAAAGAAAGAAATTTAATTGAAATTACA~GATTGAAGATGAAATTGTTTGATTGGTATATGGTTAGAGAACCAATTTTAAACATTAATGA~TAAAGATTATAAAAAA 
P e u P D D K E R N L I E I T K R V I E D E I V *  
PebB M K L F D W Y M V R E P I L N I N D L K I I K K  
AAATAACCTTAATGATGATGAATACTTAAATATGCTTATAACCTTTATTTTTGATAAAGGATTAGATGTGTGC~ATGCCATGCTAATATTGAACTTTTTAGCATTATAAAAAATTATCA 
PepB N N L N D D E Y L B M L I T F I F D K G L D V C L C H A N I E L F S I I K N Y Q  
AAATATAAATTTATCTAAAAAGAAGAAAAAAAATTTATCATTAAGTTTATACAATTATATTACACGTATGATTTTAAGATCTACACCATTTGGGTTTATGTCATCTATAAATATAAAAGC 
PepB N I N L S K K K K K N L S L S L Y N Y I T R M I L R S T P F G F M S S I N I K A  
ATTAGATACTACAAATCCAATATGGAACAATTATGCAAAAAAATATAATTTAGAAATTGACTCAAGATTACTTTACCCGCTAATAAATAAATTAAATATAGTTGTAAAAAATGAATTATA 
Pep8 L D T T N P I W N N Y A K K Y N L E I D S R L L Y P L I N K L N I V V K N E L Y  
TCTAAAAAAAAATTCTAATGTTTACGAAGATACAACTCATTTTTATATCCCATATCAAATGCAATTAGAAGGAACAAATACAGTACCTAATAATATTAGTGTGAAAAAGAATGAACTGTC 
PepB L K K N S N V Y E D T T H F Y I P Y Q H Q L E G T N T V P N N  I S V K K N E L S  
TAAATTCATATTTACTAAATTAAATAATATGTTGTACAAAGATCTAGTAAAATTAGTTGAAGATGAATTCGACGCAGATACTATCATGGTTGAAACATACTTAGATAAATTGATAGAGGA 
Peps K F I F T K L N N M L Y K D L V K L V E D E F D A D T I M V E T Y L D K L I E E  
AAATTTTATAGTTACTGAACTAGAAGATGCTATCAGTCATAAAGATCGTGACATATTCTTGATAAAAAAATTAGAACAAAAAGGGTTTTCTAATAGTTATTATTATAAGGCTTTAAAAGA 
PepB N F I V T E L E D A I S H K D R D I F L I K K L E Q K G F S N S Y Y Y K A L K E  
AATATACGATATTCGTCAAATTATGGAAAAAGGGAATATACATGACGATATACTGTATCGAATTATAGAGGTAAAAAAATTTTTAAAAGAAAAGTTTAATTTAGATGTTCACAATATTTT 
Peps I Y D I R Q I M E K G N I H D D I L Y R I I E V K K F L K E K F N L D V H N I F  
TAAAGTAGACACTATAGATACTAATATCGAAATCGATTTATCTAAATCTGAAATAAATAACATAAAAAAAGTAATCGATATGCTTCTTTACTTACCAAGTGATTATGATAATAGTTTACA 
PepB K V D T I D T N I E I D L S K S E I N N I K K V I D M L L Y L P S D Y D N S L Q  
AGAATATAAIAACAAATTTTTAGAAATATATCGTCAAGATGAATATGTTAATATTCTTAAACTTTTAAATAAAAATACAGGAATCCAATATCCTATTAATATTTATAATAATAAAGCCTT 
PepB E Y K N K F L E I Y G Q D E Y V N I L K L L N K N T G I Q Y P I N  I Y N N K A F  
TCAATATAATAATGAAAAAGTTTATTCTCTTTTAACTGAATGGCAGTATAAAGCCATTAGAGACAAAACAGATATAATACTTAATGAAGAAAGAATAGAACTATTGAAAAGAGTGGGGAA 
PepB Q Y N N E K V Y S L L T E W Q Y K A I R D K T D I I L N E E R I E L L K R V G K  
AAAACCTATTGATAAATCGTTTGATATGGTTTTTACTGTTACTAAAGATGGATTTAACAATAATATTTATCATTTAAACGATAATGTTACGTCTTTAAAGGCTACTAATATATATGGGCG 
Pep8 K P I D K S F D N V F T V T K D G F N N N I Y H L N D N V T S L K A T N I Y G R  
TTTTCGTTATTTAAATACTAAATATTTTGAAGAACAATTAAATAAATTCCCAGATTCTGTTGGAGTGCCTTCAGATAATTTAAACTATCATCATCCTAATCCCATTATTGACAATGTTAA 
PepB F R Y L N T K Y F E E Q L N K F P D S V G V P S D N L N Y H H P N P I I D N V K  
63 
2400 
26 
2520 
60 
2640 
25 
2760 
65 
2880 
105 
3000 
145 
3120 
185 
3240 
225 
3360 
265 
3480 
285 
24 
3600 
64 
3720 
104 
3840 
144 
3960 
184 
4080 
224 
4200 
264 
4320 
304 
4440 
344 
384 
4680 
424 
4800 
464 
4920 
504 
4560 
Fig.2. Nucleotide sequence of the 7.9-kbp fragment of pED503 shown in Fig. 1 and deduced amino acid sequences of PepT (opposite 
orientation), PepI, PepA, PepP, PepB and PepC. Putative ribosome-binding sites (RBS) are boxed, the putative promoters (p-35, p-I 0)  of p q d  
and prpA are marked above the sequence; the transcription start sites are indicated by arrows, the inverted repeats between prpA and pepP and 
downstream of pepC are marked with lines. 
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ATTTAAAAGTATATTTTTTGATAAGCAGACAAGCTTTACAGATATTTTTGTTTTTTTAGGAGAAGATTTAAATTTTTATTTAAAAAATTTAAAAAATGGTGAAACTTTCATACCAAAAAT 5040 
PepB F K S I F F D K Q T S F T D I F V F L G E D L N F Y L K H L K N G E T F I P K I  544 
TTCAGATATGCATAATACTCAATATICTCCAAATTTA~TTGATTTTCTTTCTAAAGTAGAAAATCAATTTATACAAGAATATTGGAATATAGAAAATTATCTAAGTGATTATACTTTTCT 5160 
PepB S D M H N T Q Y S P N L I D F L S K V E N Q F I Q E Y W N I E N Y L S D Y T F L  584 
TCCAAGAATTGTATATAAAAATATAATCATTTCTCCTAGAAAATGGAAAATCAATTTTTTAGAAAAAATAGAAAACTATAGTCAGTTTATAAAAATATTTTTAGCTAAAAAAGACGAATT 5280 
Peps P R I V Y K N I I I S P R K W K I N F L E K I E N Y S Q F I K I F L A K K D E L  624 
ATTAATTCCCAATCGTTTCTATATCCAACAAGCTGATTTGAAAATATATATCGATTTAGAAAATGAACGATGCATGGAAATATTATTTAAAGAAAGCAAAAAAAACATTTCAATTATTAT 5400 
PepB L I P N R F Y I Q Q A D L K I Y I D L E N E R C M E I L F K E S K K N I S I I  I 6 6 4  
TGTAGAAATAGAAAAAAATTTATTACAAAATAAAAAAGTTAAAGAAGCTGTTTTTTCTATAAAATCAGATTTGCATCAAGAAATTAATTATAACTATATGATGAAAAAAGATCATATACC 5520 
Peps V E I E K N L L P H K K V K E A V F S I K S D L H Q E I N Y N Y M M K K D H  I P  704 
AAATTTAAGTAAAGAAATACTATATATTGATGATGGGTGGATTAGTGTAAACTTATATTATAATGATAACAATATTAACAAATTTATTGGGGAATTTTI~TAAC~AATATATTTGAAAG 5640 
Pep0 N L S K E I L Y I D D G W I S V N L Y Y N D N N I N K F I G E F F L T N I F E S  744 
TGAAAATTTTTCAGATATAAAATACITTA~AGATATGCAGATGAAAAAGAACATATTAGA~AAGAATGAAATTAGAGTTTGATCAAGTAAAATCTGCATTACATCTTTTCAAAGAAAT 5760 
PepB E N F S D I K Y F I R Y A D E K E H I R L R M K L E F D Q V K S A L H L F K E V  784 
GGTCGATTTGAATTATATTATTGATTATAAAATAGTACC~ATTACAGAGAAACATATAGATATGGCGGAAAAGAAGTAATCGAAATAGTAGAAGCTTGTTTTGAAAAGGATTCAGAAAT 5880 
PepB V D L N Y I I D Y K I V P Y Y R E T Y R Y G G K E V I E I V E A C F E K D S E I  824 
TGTTTCCAAATTITATGCATATAGTAATATTTCTAGCAAGGAAAAGCTGTATTTTAATATACTAAATATTTTCGATATACITTCTTATTTITCAGAATCTATAAATGATAAAATAACTTT 6000 
Peps V S K F Y A Y S N  I S S K E K L Y F N I L N I F D I L S Y F S E S I N D K I T F  864 
TTTTAAAGATATAAATCATAAAGTTCAAAATAAAAAAATATATAGAAAGTATAAGGATAACTTATTAAAAACTTTAAATGGA~CTTATGAAGAAAATTATAACTCATATTTATCTATAAG 6120 
PepB F K D I N H K V Q N K K I Y R K Y K D N L L K T L N G S Y E E N Y N S Y L S I R  904 
AAGGAAAGAATATCAAAAATTAlAlGAAAAGAAGCACTAAAATATGAAGAGGTTAATTATAAAAAAAGTATTATATTAAGTATAGTTCATATGTTTAATAATAGACTTTCAGGTATCAATAGAGA 6240 
Pep0 R K E Y Q K L K E A L K Y E E V N Y K K S I I L S I V H M F N N R L S G I N R E  944 
RBS 
ACATGAAGAATTAGTAATGGA~TTCGCATCTAGGACATTAATTGATTATCAAAACA~~ATT?ATGAATA~AT~TTAAATAC~ATATTAAACAAGTAACAAATATTGACAAT 
PepC H N R F L N T Y I K Q V T N I D N  
PepB H E E L V H E F A S R T L I D Y Q N M R K Y L * 
P e p C V D S Y I N N L Y G P E P I Y K A S L I T G Y P G I A I S L F A I Y K E T N N F  
P e p C E Y Y E L C N K Y L E K T I E L I N D T P M Y S T S L F E G A F G T I F S L L V  
P e p C C S D S G S N Y S Y I I K N L L F E Y K K I S K N E I D R L R T K L K N N N I Q  
GTAGACTCTTATATAAATAATTTATACGGTCCAGAACCAATTTACAAAGCTAGTTTAATTACTGGGTATCCT~AATAGCTATAAGTCTTTTTGCTATTTATAAGGAAACCAATAATTTC 
GAATATTATGAACT~GTAATAAATATTTAGAAAAAACAATTGAGTTGATTAATGATACTCCTATGTATTCTACCAGTTTAT~GAAGGTGCTITTGGAACTATTTTTTCACTC~AGTA 
TGTTCAGATTCAGGGAGTAACTATAGTAATATCATTAAAAATITATTAT~GAATATAAAAAAATATCAAAAAATGAAATAGATAGGTTAAGAACAAAATTAAAAAATAATAATATTCAA 
TTCTATGAATTTGATATTATATCTGGATGTGCTGGAACTCTCTCACTTTTATTATTGGCTA~GATATATTTCCTGAATTATCAGAGTIACTAGTTGATGAGATTGTACAAATAACATCA 
ATTTTAACAGAATTAGTTATTAAATTTAATAATGATGACTACTTATTAGATACAATCTTGAGTAATTTAGGTTACGCACATGGTATACCAGGAATTATTAATACTTTATGTAATTCATAT 
AAAAGAGGGTATGGAATTATTAAAACAAAAAAAATCTTAGAACAAAGTATTTTCACATTATTGCAAAATCTCAAGTTGGAGAATGGAACTATTTATATCCCAAATGACATAGAATCACCT 
AATGATTATAGAGATGCTTGGTGCTATGGCTTGCCTTCAGTCGC~ATACAATATTTAATGTTTCAAGCACTCTGAAAAATAAGTCATTAlAlGAATTGAACTATCAGAAAGTTAlAlGTATTGCATCAA 
GTATTTTTGAGAAGTGATAATGCCACTAAGCTCATATCTCCTACGTTATGTCATGGATTTTCTGGAGTAGTTATGATTTCTTTATTAATGAATAATAATGAATTATCAAGTAAATATCAA 
AAGAAAATTATTCAATCTTACATTGACCAAATTGATGGTTTATA~TTGATATTAATGATCCTTCTAATTTTTCTAAAGATATCGGTTTATTAAATGGAAATGCGGGAATTTTATTAACA 
CTTCTTTCATATGATAATAATAAATTAATCAATATTAGGTGGTTCGATTTTATGATTATGTCTTAAACATAATTATAAAATATTTATTATACAA~ATCACTACTGTTAAATATTGACAC 
P e p C F Y E F D I I S G C A G T L S L L L L A T D I F P E L S E L L V D E I V P I T S  
P e p C I L T E L V I K F N N D D Y L L D T I L S N L G Y A H G I P G I I N T L C N S Y  
P e p C K R G Y G I I K T K K I L E Q S I F T L L ~ N L K L E N G T I Y I P N D I E S P  
P e p C N D Y R D A U C Y G L P S V A Y T I F N V S S T L K N K S L I E L S E S L L H Q  
P e p C V F L R S D N A T K L I S P T L C H G F S G V V M I S L L M N N N E L S S K Y Q  
P e p C K K I I Q S Y I D Q I D G L Y F D I N D P S N F S K D I G L L N G N A G I L L T  
P e p C L L S Y D N N K L I N I R W F D F M I n S +  
6360 
17 
967 
6480 
57 
6600 
97 
6720 
137 
6840 
177 
6960 
217 
7080 
257 
7200 
297 
7320 
337 
7440 
377 
7560 
398 
TTTATAAAAAGACAATAATTGTATAATAAACATTCATAAATTAAAAATCATTAATAT-A~A~~TTTTTGTTCICTCTTTTCTTATTTTATTATTAAAATCTCATAATAG 7680 
ATAATTACTATCCGTTTTAAAACGCTGTGAGAAACGCTCATTTGCATTGACAAACAGTTTATTAAC~AAATCATTGTC~TA~TAATT~ATAAATAG~TGTCTTGTTATATTTACTT 7800 
CTTTGGCAATCTTGCTAATAGCTTTGCCTTCTTCTAACATTTCCACAACTCGATGATAAATAATGCGTTTTT 
Fig. 2. (continued). 
7872 
1600 
I000 
400 
300 
Fig. 3. Northern blot analysis of pepZ and pepA transcription. Lane 
1, size standard (nucleotides); lanes 2-5, hybridization with a pepl- 
specific probe; RNA was prepared from cells taken after 1 min (lane 3), 
2 min (4) and 5 min ( 5 )  of incubation in the presence of rifampicin; lane 
2, control without rifamipicin; lanes 6-9, detection with a pepA-specific 
probe; lane 6, 0 min; lane 7, 10 min; lane 8, 20 min; lane 9, 40-min 
incubation in the presence of rifampicin. 
RXXWCYG motif around position 300 and a consensus CHG 
some 48 residues further towards the C-terminus (Fig. 7). 
Role of PepC in Pep5 biosynthesis. In order to demonstrate the 
necessity of pepC for Pep5 biosynthesis, the 6.8-kbp fragment 
of pED503 was shortened to 5.7 kbp with SpeI (Fig. I), thereby 
deleting the 231 C-terminal amino acids of pepC. The corre- 
sponding clone S.  epidennidis 5 PepY pCM7 was not able to 
inhibit our standard indicator strain S. simulans 22 but produced 
a small inhibition zone when tested against S. carnosus TM300. 
This indicated that, just as with the protease-deficient clone, in- 
completely modified or fragmented Pep5 may be produced, al- 
though only intracellular accumulation of pre-Pep5 was visible 
(Fig. 5 B). The culture supernatant of the PepC-deficient clone 
was subjected to the routine Pep5 purification protocol. Five 
major peaks and a number of smaller peaks and peak shoulders 
eluted from the HPLC reverse-phase column (Fig. 8). The five 
peaks were lyophilized, treated with dithioerythritol and rechro- 
matographed; each of these five peaks split into several further 
peaks indicative of disulfide bond formation between different 
peptides during purification. After rechromatography we iden- 
tified three major peptides (designated peptides 1, 3 and 5 )  as 
the dominant species in peaks I, 111, and V, which also occurred 
in smaller amounts in peaks I1 and IV (Fig. 8). Peak I1 also 
contained peptide 3, possibly linked to peptide 1 by intermolec- 
ular disulfide bonds, whereas peak IV contained peptide 5 as 
well as peptide 5 with a surplus water molecule. The molec- 
ular masses, amino acid composition data and N-terminal amino 
acid sequences of the three major components clearly identified 
them as degradation products of incompletely modified Pep5 
(Table 2). 
Hydrolysates of these fragments did not contain Thr and Ser; 
only one of the Pep5 fragments which was found in peak IV 
contained one Ser residue; this most likely corresponds to the 
incompletely dehydrated Pep5 peptides observed with our Pep5 
expression system (Bierbaum et al., 1994). Lan and MeLan also 
were not detectable except for one residue in the major peptide 
4x4 Meyer et al. (Eur. J. Binchem. 232) 
PepP MKSNHTYIKQTITDS--------------ILFIDSGCDFKHPELQD-----NIILKQ---------SKSFVDDNISDYTGHGTQIISVLTGK 64 
EpiP (113)-SHDLFDRQUDMRKITNEGKSYXLSPDRKKllKVALVDSGVNSSHTDLKS--INKIVNEVPKNGFRGSENDESGNKNFEEDKLNHGTLVAGQIGAN 205 
Wisp (223)-SHDFUDYQUDMKYVTNNGESYALYQPSKKISVGIIDSGIMEEHPDLSNSLGNYFKNLVPKGGFDNEEPDETGNPSDIVDKMGHGTEVAGQITAN 317 . .* , .*** * .t .*** 
PepP HYISGFLPNINIVLYKVTNFYGKSKAIDIYKALKIGIKNNFKVINISFSGEIYDKKLMKK---------FQSIIYEA---YKKNIVICUSSMN---NLQK 149 
EpiP GNLKGVNPGVEMNVYRVFGSK-KSEMLUVSKGIIDAANDDNDVINVSLGNYLIKDNQNKKKLRDDEKVDYDALQKAINYAQKKGSIVVAAVGNDGINVKK 304 
NisP GNILGVAPGITVNIYRVFGEN-LSKSEYVARAIRRAAD~NKVINISAG~YLMISGSYDDGTNDY~--EYLNYKSAINYATAKGSIVVAALGNDSLNIQD 414
. 8 t.. . .*.* , * . . . ***.* . *. .. . * *. .  
PepP SAWHG------------NKN-MVPNQLEKVFKIGDLNYYNS~FVAPGG----~INGN----ELEEITTMIVANT~VQKISDHYMGLPIGYTLNMGNS 228
EpiP VKEIN--KKRNLNSKTSKKVYDSPANLNNVMTVGSIDDNDYISEFSNYGNXFIDL~TIGGSYKLLDKYGKDAYLEKGYMQK~SVLSTSSNGRYIYQSCTS 402 
NisP NQTMINFLKRFRSIKVPGKVVDAPSVFEDVIAVGGIffiYGNISDFSNIG--ADAIYAPAGTTANFKKYGQDKFVSQGYYLKDULFTTANTGUYQYVYGNS 512 
t * . * .  . . *  * * *.* 
PepP IATSYASGCFMLIISTFKNKN-----KRYPSINEIISLISKYDDKERNLIEITKRVIEDEIV---------------------- 285 
EpiP LAAPKVSGALALEIDKYQLKDQPE--TAIELFKKKGIEKEKYMDKKHYGNGK-----LDVYK------------LLKE------ 461 
NisP FATPKVSGALALVVDKYGIKN-PNQLKRFLLMNSPEVNGNRVLNIVDLLNGKNKAFSLDTDKGQDDAINHKSMENLKESRDTMK 595 -(682) 
f .  **. 8 . . * * 
Fig.4. Partial sequence alignment of PepP, EpiP and NisP. Sequences were compared with the Clustal W software. Identical amino acids are 
marked by asterisks and conservatively exchanged amino acids are marked by dots. 
Table 2. Peptides produced by the pepC-deficient mutant S. epidermidis 5 Pep9 pCM7. 
Peptide N-terminal Molecular mass Pep5 fragment Lan/MeLan Amino acids found (present in the prepeptide) 
sequence measured (theoretical) found 
Ser Thr c y s  
Da mol/mol peptide 
1 blocked 2766.0 2 0.1 (2767) 9-34 1 0 (2) 0 ( 3 )  2 (3) 
3 I-R- A-blocked 2575.5 ? 0.5 (2577) 6-29 0 0 (2) 0 ( 3 )  2 (2) 
5 blocked 2955.6 2 0.6 (2959) 1-29 0 0 (2) 0 (3) 2 (2) 
A 
B 
Fig. 5. (A) SDSPAGE separation of Pep5 peptides partiafly purified 
from the supernatant of S. epidermidis 5 and of its indicated vari- 
ants. (3) Western blot of total cell extracts of the respective strains 
immunoblotted with anti-Pep5 leader peptide antiserum for detec- 
tion of Pep5 prepeptides. (A) Lane 1, molecular mass standard (Da); 
lane 2, purified Pep5, 2.5 pg; lane 3, wild-type S. epidermidiv 5 ;  lane 4, 
S. epiderrnidis 5 PepY pGB10R; lane 5 ,  S. epidermidis 5 Peps-pCRO1 ; 
lane 6, S. epidermidis 5 Pep5 pCM7; lane 7, S. epidermidis 5 Peps- 
pMR4; lane 8, S. epidermidis 5 PepY pMR7; lane 9, S. epidermidis 5 
Pep5 -. (B) Lane 1 ,  biotinylated molecular mass standard (Da); lane 2, 
wild-type S. epidermidis 5 ;  lane 3, S. epidermidis 5 Pep5- pGB1OR; 
lane 4, S. epidermidis 5 Pep5 pGRO1; lanes 5, 6, S. epidermidis 5 
Pep5 pGRO1 (culture supernatant); lane 7, S. epidermidis 5 Peps- 
pCM7; lane 8, S. epidermidis 5 Peps- pMR4; lane 9, S. epidermidis 5 
PepS~ pMR7; lane 10, S. epidermidis 5 Peps-. 
fragment 1 (Table 2). We analyzed the major peptides for the 
presence of free Cys residues using Ellman’s reagent and subse- 
quent mass spectrometry. With peptide 1 (Table 2) addition of 
two Ellman reagent molecules was possible (Fig. 9) indicative 
of two free Cys residues. Only traces of addition products of 
peptides 3 and 5 were detectable despite dithioerythritol treat- 
ment before chromatography, indicative of rapid intramolecular 
disulfide bond formation under oxidative conditions. Dithioer- 
ythritol treatment and addition of excess Ellman’s reagent 
shortly before mass spectroscopy increased the amount of addi- 
tion products. The presence of disulfide bonds is also indicated 
by a difference of 1.5 -2 Da between the calculated and detected 
masses, although such interpretations must take into account the 
limited accuracy of such a measurement. 
We interpret the results compiled in Table 2 as follows. Pep- 
tide fragment 1 (9-34) has three Cys residues, one of which 
forms a thioether. Bridge formation could occur anywhere in the 
peptide except with Dha9, because lanthionine formation with 
Dha9 would just lead to a blank cycle, but not to a block during 
N-terminal sequencing. Also Cys33 is likely to be part of this 
thioether because peptide 1, unlike peptides 3 and 5 ,  is not frag- 
mented at position 29; as a result of the removal of ring C by 
site-directed mutagenesis, we found fragmentation at Gly29 to 
occur rather rapidly (Bierbaum et al., unpublished). The Ianthio- 
nine ring in peptide 1 could impose conformational constraints 
on the peptide which does not allow for the remaining two Cys 
residues to form a disulfide bond; in contrast, this can occur 
rapidly with peptides 3 (fragment 6-29) and 5 (fragment 1 - 
29) which just contain two Cys residues each. 
These Pep5 fragments had no detectable antimicrobial activ- 
ity as determined as inhibition zones in a lawn of S. carnosus 
TM300. Some activity eluted close to peak IV (Fig. 8) and was 
directly detectable without concentrating the fraction ; obviously, 
a small amount of a peptide with a higher specific activity is 
also produced which, however, could not be separated and puri- 
fied for further characterization. 
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PepB --HKLFDUYMVREPILNINDLKIIKKNNLNDDEYLNMLITFIFDKGLDVCLCHANIELFSIIKNYQNIN--LSKKKKKNLSLSLYNYITRILRSTPFCF 96 
EpiB GEIELDNIFVPSNIYMVRTPIFSIELYNQFLKSDNIDYDLIL~NDIFKESIMTTTYNLY~SIGKIDUE---KDNKKTRNVKESLLKYLI~STRSTPYGM 97 
NisB ----MIKSSFKA9PFLVRNTILCPNDK-RSFTEYTQVIETVSKNKVFLEQLLLANPKLYDV~qKYNAG--LLKKKRVKKLFESIYKYYKRSYLRSTPFGL 93 
SpaB ----HKSLYTPTDYYHIRVPLVH9DLKNENSPDID9LLHDLCNDSLFREPILVSSRTLYETIHTFLQAPDKLKGKKKRNFPQAILKYATRRATRTTPFCL 96 
. .  . . 8 . .  I. . , .  * * * .** .*  
PepB HSSINIKALDTTNPIWNNY--AKKYNLEIDSRLLYPLINKLNIVVK-NELYW(K-NSNVYEDTTHFYIPY~~QLEGTNTVPNNISVKKNELSKFIFTKLN 192 
EpiB LSGVALCEFSENNNIKIKDSSFHKKDVKIDGQULYKLVHYLESDYTYYKDSFVIWNQQNYIYNNRLYLDNNSSITENKRNDV-LSVKYNSILVFIHENSK 196 
NisB FSETSICVFSKSSQYKLHG--KTTKGIRLDTqULIRLVHKHEVDFS-KKLSFTR-NNANYKFGDRVFQVYTINSSELEE----VNIKYTNVYqIISEFCE 185 
SpaB FSSVCIGSFSDKNHLSFN~H-SFYKKARVDFEULY~LI~LENEYT-DRLSFTL-NSACYIKGDRAYLLYSTDG-KSEE----VSV~TSVFYLINELCG 188 
* .  . .  . . . . .  t * .  . *  I t. . 
Peps --NMLYKDLVKLVEDEFDADT-IMVETYLDKLIE~NFIVTELEDAISHKDRDIFLIKKLE~KGFSNSYYYKALKEIYDIR~IMEKGNIHDDILYRIIEVK 289 
EpiB -KNITYEELVQLISSKYSIENKEEVKVFV~ELINKEIIFSDLRPTLENKNP~YIINSLNPK---NSLVGTLINISNEITKYSKMPLG--KCEYKYLDIV 290 
NisB NDY9KYEDICETVTLCYGDEYRELSEQYLGSLIVNHYLISNL~KDLLSDFSWNTFLTKVEAIDEDKKYIIPLKKV~KFIQEYSEIEIG--EGIEKLKEIY 283 
SpaB -ESAAY~DIIRCLIDNYPNTPINKINPYYADLIDKEFLISNLRPPMTVSDQF~YLID~AESRHIPNELI~ACKNIQYQIDAYNRITIG--EGEH~YLNLI 285 
4 . .  * . .  . . .. lit . . * . 
Pep6 KFLKEKFNLDVHNIFKVDTIDTNIEIDLSKSEINNIKKVIDMLLYLPSDYDNSL---~EYKNKFLEIYGQDEYVNILKLLNKNTGI~YPIN-------IY 379 
EpiB NLMSQLFVSK--NYL9IDTYIDYSRNELKUSLADNISEAAYILULLSPNHFGTKT-IRNYHEFFMDKYGFEOLVNLKOLLSDINGFGYPK------K~SY ? R l  
NisB 
Spa6 
Pep0 
EpiB 
NisB 
Spas 
Peps 
EpiB 
.~~~ ~ ... . ~~ ~ 
QEMSQILEND--NYIQIDLIS-DSEINFDVKQKqQLEHLAEFLGNTTKSVRRTY- -LDDYKDKFIEKYGVDQEVqITELFDSTFGICAPYNYNHPRNDFY 
ETMNKLIKAS--SPLPVDAGAGDSSIQLDNETSLAISELASMFTYMASPSANTLDHLEKYKNVFLERYGYEREVPLLEMLCSSTGIGAPATYTNPANEFF 
. .* * .  *.. ** . * . . * 1 
NNKAFQYNN-EKVYSLLTEU~YKAIRDKTDIILNEERIELLKRVG--KKPIDKSFDMVFTVTKDGFNNNIYHLNDNVTSLKATNIYGRFR------YLNT 
-SFSNNIAFLKEKYLLAIQNNSHIEITENDVKNLEKNNTVSKINAPVSTEIYS--EIYFGNSIKGYE-DFAVISPILGSFNAGATFGRFTGNFNIKKKN~ 
ESEPSTLYYSEEEREKYLSHYVEAVKNHNVINLDDLESHYQKMDLEKKSELqG-LELFLNLAKEYEK-DIFILGDIVGNNNLGGASGRFS---ALSPELT 
EETSFGEQFSPEMK9FFMRKYFESVRKKAPIqLDDETFHRICNSEIADEEIPLSFELNFFVKLRNGR-VKLYLGPNVGSTRAGKTFGRFS---HMSDSIS 
. .  . . .  . .  I** 
KYFEEqLN--KFPDSVC-VPSDNLNYHHPNPIIDNVKFKSIFFDKqTSFTD------------IFVFLGEDLN--FYLKNLKNGETFIPKISDMHNTqYS 
L~KEIVHHYNNYMNENC-LEIS~LNEGPLNSRNVNILNNNRIYNTCLNLNL--PKSD---IDINDIFIGATFN-KLYLYSEKHDSRIVFVSNSMFNYEFG 
_ _ _  
378 
383 
470 
477 
473 
479 
553 
570 
NisB SYHRTIVDSVERENENKEITSCEIVFLPENIRHANVMHTSIMRRKVLPFFT-STSHN--EVLLTNIYICIDEKEKFYARDIST~EVLKFYITS~YNKTLF 570 
SpaB EIIKTLHNKEKELTECN-TKVCELSIVPWPTRSCWVTRNVSYREKEMSLFTNSALHLNDSVKAEDILIGINKDHIFYARHKTTGEILSFESNHMFNPLLM 578 
. . *  * .  
Pep6 PNLIDFLSKVEP~FIQ--EYUNIENYLSDYTFLPRIVYKNIIISPRKUKINFLWIEsYS ----QFIKIFLAKKDELLIPNRFYIQQADLKIYIDLEWE 646 
EpiB SELYKFLREISFEKTKFIPPITEEGIDS-LPFCPRIIYKNIILKPATUKINSEUFS~EN------WLNRFATIREKWHIPKDVIIAFGDNRLLLNLl~ND 663 
N i s B  SNELRFLYEISLDDK--FCNLPUELIYRDFDYIPRLVFDEIVISPAKUKIUGRDVNS---------KHT1RELIPS-KEIPKEFYIVNGDNKVYLSQKNP 658 
Spa6 TNAVRLLLEISRDCKRKWNDFPUFSIYSDFKYIPEIKYKEITLSCE~ULIYKNDLSMHSNASLEEIKSAFFEFHRT-YELP~TFYIVNADNRLLIDI~ND 677 
* .  . 1 . . . , I . . . . . . , , . . 
Pep6 RC~EILFKESKKNISII-----IVEIEKNLLQNKKVKEAVFSIKSDLHOEINYNYM~KKDHIPN---LSKEILYID~UISVNLYYNDNNINKFIGEFFL 738 
Ep1B KHLIILKKELKKHCRIR-------ILES--FINESNNERHLEIVTPLYKKTSLKE--PSFIIPK---NRNKHFNNLKDUFSIHLSIPKTYqDNFI~DYLL 749 
N i s B  LD~EILESAIKKSSKRKDFIEL~EYFEDENIINKGFKGRVADVVVPFIRTRALGNEGRAFIREKRVSVERREKLPFNEULYLKLYISINR~NEFLLSYLP 758 
Spa6 CTLDVFFWELKKTNHN9PLQLVAVEHDADALKDRN~NDYSGEIVVPLLRKqPVKPLYLPVI.NAIECSCSDRIKMPFEDWLFIKLYCKUT~EEELIAFEIA 777 
. , .. * .  
Pep6 TNIFESEN--FSDIKYFIRYADEKEHIRLRH--KLE--FD~VKSALHLFKE~VDLNYIIDYKIVPYYRETYRYGGKEVIEIVEACFEKDSEIVSKFYAY- 831 
EpiB P F I T E L K V N N F I N K F F Y I K F K E D E D F I K L R L L R E D E D Y S 9 D Y V P E V Y R Y G G P H V I E D I E N F F M Y D S L L S I N I I ~ - -  847 
NisB DIQKIVAN--LGCNLFFLRYTDPKPHIRLRI--KCSDLFLAYGSILEILKRSRKNRI~ST~DISIYD~EVERYGGFDTLELSEAIFCADSKIIPNLLTL? 854 
Spas DFYN9ISD9-YPVRHFFMRYRDPKPHIRLRFNGKAEVLYSLFPULLNULKSLREKGLVSE~VITUYEREIERYGGLSL~EAAE~LFCEDSKVVEMHIR~H 876 . , . I  . I * .... , *  . * t. . .  
Pep6 --SNISSKEKLYFNILNIFDILSYFSESINDKITFFKDIWHKV~NKKIYRKYKDNLLKTLNGSYEENYNSYLSIRRKEY~KLKE-~----ALKYEEVNYK 923 
EpiB --SEFKIP-KEFIVAISIDFLLDYLEINKSEKEEILINNAEDLYRSNDIREYKNLLAKLTNPKN--DYEILKKEFPNLHEFLFNKISILENLKKTLq~SL 942 
NisB KDTNNDWKVDDVSILVNYLYLKCFF9WDNKKILNF~N-LVSTKKVKENVNEKIEHYLKUKVNNLGDqIFYDKNFKELKHAIKN- ---LFLKHIAQDF 947 
SpaB RMKDITIS-KEIACMVSVI~FLE~FELTFEEOLTFL~RNSL~NEYRTEFKKDREMYIEICNSDRDUDNLKKTSDGGMLYETL~TRK~AAAHYAFLIKKAF 975
Pop6 K------SIILSIVHHFNNRLSGINREHEELVMEFASRTLIDYqNMRKYL----- 967 
EpiB YTS--RSRIIGSFIHMRCNRIFGINPEKEKFVLSIFN~ITKTKKYUDGCD----. 995 
N i s B  ELQ-KVYSIIDjIIHVHNNRLIG[ERDKEKLIYYTL~RLFVSEEYMK-------- 993 
SpaB DNKDEVYSRICSIIHLHCNRLFGTDRFLENKILTLCRHSLYAQRY~KMNGSLAUK 1330 ...., i . *  , . .  
Fig. 6. Sequence alignment of PepB, Epit), NisB and SpaB as described for Fig. 4. 
A transporter gene, pepT, is located upstream of pepA. An- 
other open reading frame in reverse orientation was found up- 
stream of pep1 which codes for a putative protein of 571 amino 
acids with a molecular mass of 64.8 kDa. Data base searches 
revealed similarities to the LanT proteins of the biosynthetic 
gene clusters for epidermin (EpiT'/EpiT"), subtilin (SpaT) and 
nisin (NisT). The highest degree of similarity with 30% identical 
and 24% conservatively exchanged amino acids was found be- 
tween PepT and EpiT'/EpiT". PepT shows the typical features 
of the ABC transporter protein family; the N-terminal domain 
covering the first 300 amino acids is predicted to contain six 
membrane-spanning segments while the C-terminal domain is 
hydrophilic and includes the ATP-binding site formed by the 
conserved Walker motifs A (amino acids 362-373) and B 
(amino acids 470-482) (Fig. 2) .  
Western blot and SDSEAGE analysis of Pep5 production. 
Complementation of S. epidermidis 5 Peps- with pepIAPBC 
resulted in a clone (pGB1OR; Bierbaum et al., 1994) which 
produced approximately 10% of the amount of Pep5 as com- 
pared to the wild-type producer (Fig. 5A, lane 4). After deletion 
of the C-terminal part of pepC from this construct the amount 
of peptide excreted increased (lane 6), while after inactivation 
of pepP hardly any peptide was detectable (lane 5). Neither the 
clones pMR4 and pMR7, harbouring only pepIAP and pepA, 
respectively, excreted any peptide in the size range of Pep5 
(lanes 7,8) nor did the host control S. epidermidis 5 Pep5- (lane 
Western blot analysis of SDS cell extracts from the same 
clones using antiserum raised against Pep5 leader peptide indi- 
cated that, in particular, clones pMR4 and pMR7 accumulated 
prepeptides inside the cells (Fig. 5 B, lanes 8, 9). Also the extract 
of the protease-deficient clone pGROl contained considerable 
amounts of prepeptide (lane 4) in addition to the incorrectly pro- 
cessed leader peptide. In contrast, no prepeptide was detectable 
in the wild-type producer because of rapid modification and pro- 
cessing (Weil et al., 1990). Only small amounts of prepeptide 
can be found in clones pGBlOR and pCM7 (lanes 3, 7). 
9). 
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PepC --------------MNR-------------FLNTYIK-QVTNIDNVDSYINNLYGPEP-IYKASLIT--------------GYPGIAISLFAIYKETNNF 
Epic LAVLYTCVVIEYSVLILKKKNLFYLFLMKLQKLKNIGMVVININNIKKILENKITFLSDIEKATYIIENQSEYWDPYTLSHGYPGIILFLSASEKVFHKD 
NisC ----------MRIMMNK------------KNIKRNVEKIIAQWDERTR--KNKENFDF--GELTLST--------------GLPGIILMLAELKNKDNSK 
spat _..._____ MERGTVSR----------IEVEIVKEMARQISNYDKVLEIVNQKDNFRS-IGEVPLIP------WKSTALSHGIPGICMLYGELHAHFPEE 
I** , . . .  
PepC EYYELCNKYLEKTIELINDTPMYSTSLFEGAFGTIFSLLVCSDSGSNYSNIIKNLLFEYKKISKNEIDRLRTKLKNNNIQFYEFDIISGCAGTLSLLLLA 
Epic -LEKVIHQYIRKLG-PYLESGIDGFSLFSGLSGIGFALDIASDKQYSY~SILEQ~DNLLVQYVFDFLN~-----DALEVTPT~YDII~GFSGIGRYLL~R 
N i s C  IYQKKIDNYIEYIVSKLSTYCLLTGSLYSCAAGIALSILHL~~DEKYKNLLDSLNRYIEYFV~KIEGF----NLENITPPDYDVIEGLSGILSYLLLI 
SpaC CWDDICHQYLSILVNEIKEKGLHTPSMFSGAAGIGLAAICLSQRFTYYNGLISSINEYLAETVPQLLTEF----DQRQVCMSDYDVIEGVSGIANYLLLF 
, f . .  * * . * . .  . , . * , *  t .* ** *. 
PepC ----------TDIFPELSELLVDEIVQIT---SILTELVIKFNN-DDYLLDTILSNLGYAHGIPGIINTLCNSYKRGYGIIKTKKILEQSIFTLLQNLKL 
Epic ---ISYNYNAKKALKHILNYFKTIHYSKD---NWLVSNEHQFLDIDKQNFPSGNINLGLAHGILGPLSLTALSKMNGIEIEGHEEFL~DFTSFLLKPEFK 
NisC N-DEQYDDLKILIINFLSNLTKENNGLIS----LYIKSENQMSQSESEMYPLGCLNMGLAHGLAGVGCILAYAHIKGYSNEASLSALQKIIFIYEKFELE 
SpaC ~EDKAMCDLLIDILKYLVRLTEDIIVDGEKVPGWHIPS~HQFTDIEKKAYPYGNFNMGLAHCIPGPICVLSSALIQGIKVKGQERAIEKMANFLLEFSEK 
. .  *.* ***. 1 . . * .. 
PepC ENG----------TIYIPNDIESPND-YRDAWCYGLPSVAYTIFNVSSTLKNKSLIELSESLLHQVFLRSDNATKLISPTLCHGFSGVVMISLLMN---N 
Epic NNN--EW-----FDRYDILENYIPNYSVRNGWCYGDTGIMNTLLLSGKALNNEGLIKMSKNILINIIDK--NNDDLISPTFCHGLASHLTIIHQANKFFN 
NisC RKKQFLWKDCLVADELKKEKVIREASFIRDA~CYCGPGISLLYLYGGLALDNDYFVDKAEKILESAMQ---RKLGIDSYMICHGYSGLIEICSLFKRLLN 
SpaC EQDSLFWKGIISFEEYQYCSPPNAVNFSRDlWCYGRPCVCLALVKAGKALQNTELINIGVQNLRYTIS---DIRGIFSPTICHGYSGIG~ILLAVNLLTG 
* ***. . .t * . * . * ** I  . * 
PepC NELSSKYQKKIIQ-----S--YIDQIDGLYFDINDPSN----FSKDIGLLNGNAGILLTLLSYDNNK-LINIRWFDFMIMS 398 
Epic LSQVSTYIDTIVR---KIISHYSEESSFMFQDIEYSYG-QKIYKNKVGILEGELGVLLALLDYIDTQNQSRKNWKNMFLIT 455 
NisC TKKFDSYMEEFNVNSEQILEEYGDESCTCFLEGISGCILVLSKFEYSINFTYWRQALLLFDDFLKG-------GK~K---- 418 
SpaC QEYFKEELQEIKq---KIMSYYDKDYIFGFHNYESMEGDEAVPLQYVGLLDGAVGVGLGVLNMELG---SKTDWTKALLI- 441 
* * 
Fig. 7. Sequence alignment of PepC, Epic, NisC and SpaC as described for Fig. 4. 
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Fig. 8. HPLC elution profile of Pep5 peptides isolated from the cul- 
ture supernatant of the PepC deficient mutant S. epidermidis 5 Peps- 
pCM7. 
DISCUSSION 
The Pep5 gene cluster. Several lantibiotic biosynthetic gene 
clusters have been sequenced so far and a general picture is 
emerging on how lantibiotic biosynthesis may proceed and 
which classes of proteins are involved. Besides several proteins 
providing general functions such as processing proteases, trans- 
porters and two-component regulators, two putative modifica- 
tion enzymes LanB and LanC have been identified. In the case 
of lactocin S (Skaugen, 1994) and lactococcin DR (Rince et al., 
1994) only one enzyme, such as LasM, which in the C-terminal 
half shares sequence similarity with the LanC proteins (Sahl et 
al., 1995) is sufficient for the modifications. 
The Pep5 biosynthetic gene cluster comprises pqTIAPBC,  
i.e. besides the structural gene and the immunity gene there is 
information for a translocator, a protease and the modification 
enzymes PepB and PepC. Genes for regulatory proteins, the reg- 
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Fig. 9. Electro-spray mass spectroscopy of peptide 1 (purified from 
peak I of the supernatant of S. epidermidis 5 Pep5- pCM7, see Fig. 8 
and Table 2) before (A) and after (B) treatment with Ellman’s rea- 
gent. The figure shows the mass range of the triply charged iun 
(m+3H)’+ resulting in peptides of 2766 Da and 3162 Da, respectively; 
the calculated mass for peptide 1 after addition of two Ellman’s reagent 
molecules is 31 62 Da. 
ulator LanR and the corresponding sensor kinase LanK, are not 
present. Both genes were found in the nisin (nisR, nisK; Klein 
et al., 1993) and subtilin (SPUR, spaK; Engelke et al., 1994) gene 
clusters, whereas in the epidermin cluster only the regulator 
EpiQ (equivalent to a LanR protein) is encoded (Schnell et al., 
1992). The absence of pepR and pepK from the Pep5 gene clus- 
ter does not necessarily imply that Pep5 production is not regu- 
lated; rather, the failure of transforming of S. carnosus TM300 
into a Pep5 producer with the plasmid pGB7 suggests that essen- 
tial information for the heterologous expression of Pep5 produc- 
tion is missing on this plasmid (Bierbaum et al., 1994). Just as 
in the case of epidermin, where the location of one gene (epiK) 
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is unknown (Peschel et al., 1993), the information for both of the 
corresponding Peps genes may be located on the chromosome or 
on one of the other four plasmids of the producer strain (Ersfeld- 
Dressen et al., 1984). 
The location of potential promoters and transcriptional ter- 
minators as indicated in Fig. 2 suggests that the structural gene 
pepA together with the genes for the essential modification and 
processing enzymes pepPBC are coordinately transcribed. The 
promoter in  front of pepA is functional as indicated by the clone 
pMR7 which only contains the structural gene and which pro- 
duces and accumulates pre-Pep5 (Fig. 5 B). Downstream of 
pepA there are no further potential promoters for pepP, pepB and 
pepC detectable. The relatively weak terminator downstream of 
pepA could allow partial readthrough, thus reducing the produc- 
tion of PepP, PepB and PepC and thereby ensuring a high 
prepeptide/enzyme ratio, while the terminator behind pepC is 
probably strong enough for transcription termination. However, 
using a pepA probe we could not detect any transcript longer 
than approximately 300 bases indicating that, if a pepAPBC tran- 
script exists, it is rapidly processed. Similar observations were 
reported for nisin (Engelke et al., 1992; Kuipers et al., 1993) 
and epidermin (Schnell et al., 1992). Although it cannot be ex- 
cluded that the short pep1 transcript also derives from process- 
ing, it could be transcribed as a monocistronic mRNA. In any 
case, it seems crucial for the Pep5-producing strain to ensure a 
balanced production ratio between the lantibiotic and the immu- 
nity peptide; it remains to be studied how this is achieved. Previ- 
ous work has shown that there is no expression of the immunity 
phenotype when pepA is deleted or truncated (Reis et al., 1994) 
and it appears not inconceivable that the prepeptide in any stage 
of modification participates in the activation of the pep1 promo- 
ter. 
Roles of PepP and PepT in Pep5 biosynthesis. The fact that 
pepZAPBC was sufficient to transform the pED503-cured variant 
of S. epidermidis 5 into a Pep5 producer demonstrates that PepT 
is not essential for Peps in the homologous host (Bierbaum et 
al., 1994). However, there are indications that the host-provided 
translocators apparently substituting for PepT are less efficient 
and that, for high production rates, PepT is indispensable. The 
strongest argument for such an interpretation is the observation 
that, in the absence of PepT, Peps yields drop to approximately 
10% (Fig. SA). The substituting transporters probably act more 
slowly because of the thioether-based ring structures ; the PepC- 
deficient strain excretes more processed Pep5 and accumulates 
less unprocessed prepeptide inside the cells than the PepP-defi- 
cient clone; a higher production was also observed with a mu- 
tated Peps molecule from which the bulky ring C had been de- 
leted by site-directed mutagenesis (Bierbaum et al., unpub- 
lished). Our results compare well with the epidermin transporter: 
epiTT'  is a discontinous gene which is not necessary for epi- 
dermin production in a heterologous host (Schnell et al., 1992; 
Augustin et al., 1992). 
In contrast, the protease PepP is essential for cleaving off 
the leader sequence after the propeptide has been modified. Our 
results show that PepP is the only protease of the producer strain 
which is able to recognize the specific cleavage site of pre-Pep5 ; 
processing by other proteases is possible but yields truncated 
peptides which show strongly reduced antibacterial activities. 
The importance of dedicated proteases is also reflected by the 
fact that, with the exception of subtilin, proteases have been 
found in all lantibiotic gene clusters sequenced so far. Like PepP, 
NisP and EpiP belong to the family of the subtilisin-like serine 
proteases (Siezen et al., 1991; Van der Meer et al., 1993) and 
both show the features of pre-pro-proteins with a characteristic 
N-terminal procaryotic secretory signal sequence and a potential 
signal peptidase cleavage site (Siezen et al., 1991; Van der Meer 
et al., 1993). In addition, the last 30 amino acids of the C-termi- 
nus of NisP show a sequence similarity to a consensus mem- 
brane anchor sequence which suggests an export across the cell 
envelope and the attachment to the cellular membrane. PepP 
does not have a signal sequence and must be located in the cyto- 
plasm because no prepeptide was detected outside the cell after 
inactivation of PepP, in contrast to the results that were obtained 
with a clone of Lactococcus lactis harbouring nisABTCIR with- 
out a functional nisP (Van der Meer et al., 1993). This also sub- 
stantiates the interpretation that Pep5 must be processed inside 
the cell. The putative ElkP protease, that is encoded in the epi- 
lancin K7 gene cluster of S. epidermidis K7 directly downstream 
of the elkA structural gene (Van de Kamp et al., 1993,  resembles 
PepP by lacking these sequence attributes and is probably also 
intracellularly located. Epilancin K7 is structurally more closely 
related to Pep5 than other lantibiotics which obviously is also 
reflected in increased organizational and functional similarities 
of the biosynthetic apparatus. 
PepC is a thioether-forming enzyme. The absence of any se- 
quence similarity to known proteins connected LanB and LanC 
proteins with the modification reactions as soon as the respective 
genes were first described (Schnell et al., 1991). In spite of this, 
there is no experimental evidence so far as to the exact function 
of these enzymes. It was assumed that one enzyme would be 
involved in dehydration of hydroxyamino acids while the other 
would catalyze the ring formation. However, spontaneous addi- 
tion of thiol groups at ambient temperature is possible and has 
been used in the structure determination of lantibiotics and, 
therefore, was discussed as an alternative (Jung, 1991). Also, it 
was not clear whether dehydration and ring formation would 
indeed be separate processes or catalyzed in one step. The con- 
struction of a PepC-deficient clone and the characterization of 
its secretion products now allows us to unambigously asign a 
function to this protein as well as to deduce the function of the 
PepB protein. 
The PepC-deficient clone secretes completely dehydrated 
Peps peptides, thus excluding the possibility that PepC is itself 
involved in dehydration. Instead, the majority of the peptides do 
not contain thioether amino acids, none of the peptides possesses 
the correct thioether pattern and just a small fraction, an esti- 
mated 20% of the total peptides purified, contains one lanthio- 
nine molecule out of three. This strongly suggests that PepC is 
responsible for thioether formation; it seems reasonable to as- 
sume that PepC binds to the dehydrated prepeptide and stabilizes 
a prepeptide conformation which enables the sulfhydryl groups 
to add to the correct dehydroamino acid. Apparently, in the ab- 
sence of PepC and consequently of thioether rings, and possibly 
also in the absence of the correct exporter PepT, which could 
create a transport bottle neck and prolong the time during which 
the peptides are exposed to intracellular proteases, unbridged 
Pep5 peptides are subject to proteolytic destruction ; particularly, 
the Gly29-Lys30 bond is susceptible to hydrolysis, a150 indicat- 
ing that in the peptide which contains one lanthionine Cys33 
may be part of the ring bridging to one of the N-terminally lo- 
cated dehydroamino acids. The partial formation of this ring 
could be facilitated by transient stabilization of a peptide struc- 
ture during some biosynthetic reaction such as processing or 
transmembrane translocation. 
Model for the biosynthesis of Pep5-type lantibiotics. The 
identification of PepC as the thioether-forming protein makes it 
very likely that the dehydration of Ser and Thr residues is cata- 
lyzed by PepB. This interpretation is supported by the previous 
isolation of completely unmodified prepeptide from clone S. 
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rpidermidis 5.- pMR7 (Sahl et al., 1991) which contains only 
the structural gene but none of the biosynthetic genes (Table 1). 
This strain accumulates the prepeptide inside the cells and does 
not secrete any processed peptide (Fig. 5). Similarly, in clone 
pMR4 which contains yepIAP but lacks peyB and pepC, only 
accumulation but no processing and secretion are detectable 
(Fig. 5). As there is no reason to assume that the immunity pep- 
tide or the protease are involved in dehydration, this function 
can only be attributed to PepB. Another interesting observation 
is that, although the protease is present in clone pMR4, obvi- 
ously processing does not take place; this indicates that PepP 
may not recognize the cleavage site unless Thr+’ is dehydrated 
to Dhb. It is also remarkable that, at least with the expression 
system used in this study where PepT is missing, Pep5 cannot 
be transported in the unprocessed form. Secretion of modified 
but uncleaved nisin in NisP-deficient clones was recently re- 
ported by Van der Meer et al. (1993), in which case however 
the processing protease is located outside the cell. 
Based on the present and previously published results (Weil 
et al., 1990; Sahl et al., 1991), it is possible to draw a rather 
precise picture of the sequence of events and cellular locations 
of the reactions leading to mature Pep5. 
a) The prepeptide is ribosomally synthesized and rapidly de- 
hydrated in its propeptide part by PepB. 
b) The dehydrated prepeptide binds to PepC which folds 
Pep5 in such a way that correct thioether formation is possible. 
c) The completely modified prepeptide is processed by PepP 
inside the cells. 
d) Mature Pep5 is exported from the cells by PepT which 
can be functionally substituted to some extent by other host- 
encoded transporters. A somewhat relaxed substrate specificity 
of ABC transporters is well documented (Fath and Kolter, 1993). 
e) PepI protects the producing cells by an as-yet-unknown 
mechanism (Reis et al., 1994). However, it is interesting to men- 
tion that PepI has no equivalent in  any other lantibiotic gene 
cluster and that processing proteases are supposed to be extracel- 
Mar proteins (Sahl et al., 1995) except in the case of Pep5, 
lactocin S (Skaugen, 1994) and epilancin K7 (Van de Kamp et 
al., 1995); it may well be that the intracellular processing of 
Pep5 requires a particular protection mechanism. 
Currently, experiments are in progress to isolate the Pep5 
biosynthetic enzymes, in particular PepB and PepC, and to ver- 
ify their functions in vitro. 
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